Absci (ABSI) Intangibles (2021 - 2026)
Absci (ABSI) reported Intangibles of $40.8 million for Q1 2026, down 7.43% on a YoY basis from $44.0 million in Q1 2025, and down 1.8% sequentially from $41.5 million in Q4 2025.
Absci (ABSI) Intangibles (2021 - 2026) Analysis & Trends
Absci (ABSI) has 6 years of Intangibles data on file, last reported at $40.8 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 7.43% year-over-year to $40.8 million; the trailing twelve-month figure through Mar 2026 stood at $40.8 million (down 7.43% YoY), and the FY2025 full-year result was $41.5 million, down 7.51% from the prior year.
- Intangibles retreated to $40.8 million in Q1 2026, from $41.5 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $53.3 million in Q2 2022 to a low of $40.8 million in Q1 2026.
- A 5-year average of $47.3 million and a median of $47.4 million in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles fell 1.63% in 2023 and retreated 7.51% in 2025, its largest moves.
- Tracing ABSI's Intangibles over 5 years: stood at $51.6 million in 2022, then fell by 6.53% to $48.3 million in 2023, then fell by 6.98% to $44.9 million in 2024, then decreased by 7.51% to $41.5 million in 2025, then dropped by 1.8% to $40.8 million in 2026.
- Business Quant data shows ABSI's Intangibles at $40.8 million in Q1 2026, $41.5 million in Q4 2025, and $42.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 40.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.77 Mn |
| Dec 31, 2025 | 41.51 Mn |
| Sep 30, 2025 | 42.36 Mn |
| Jun 30, 2025 | 43.20 Mn |
| Mar 31, 2025 | 44.04 Mn |
| Dec 31, 2024 | 44.88 Mn |
| Sep 30, 2024 | 45.73 Mn |
| Jun 30, 2024 | 46.57 Mn |
| Mar 31, 2024 | 47.41 Mn |
| Dec 31, 2023 | 48.25 Mn |
| Sep 30, 2023 | 49.10 Mn |
| Jun 30, 2023 | 49.94 Mn |
| Mar 31, 2023 | 50.78 Mn |
| Dec 31, 2022 | 51.62 Mn |
| Sep 30, 2022 | 52.47 Mn |
| Jun 30, 2022 | 53.31 Mn |
| Mar 31, 2022 | 51.62 Mn |
| Dec 31, 2021 | 54.99 Mn |
| Sep 30, 2021 | 55.84 Mn |
| Jun 30, 2021 | 56.68 Mn |